1-8 of 8
letrozole
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Syed S Ali, Wilson Mertens
Journal: Blood
Blood (2017) 130 (Supplement 1): 5165.
https://doi.org/10.1182/blood.V130.Suppl_1.5165.5165
Published: 2017
Journal Articles

Sensitizing shRNA Screen for Molecular Targets in CDK4/CDK6-Based Combination Therapy in Multiple Myeloma

Xiangao Huang, PhD, Maurizio Di Liberto, PhD, David Chiron, PhD, Ruben Niesvizky, MD, Anna C. Schinzel, PhD, William C. Hahn, MD PhD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2014) 124 (21): 3440.
https://doi.org/10.1182/blood.V124.21.3440.3440
Published: 2014
Journal Articles

Integrative Whole Transcriptome and Exome Sequencing Reveals Reprogramming Of Mantle Cell Lymphoma In Prolonged Early G1 Arrest For Clinical Response To Selective Inhibition Of CDK4 In Combination Therapy

David Chiron, PhD, Peter Martin, MD, Maurizio Di Liberto, Ph.D., Xiangao Huang, PhD, Priyanka Vijay, B.A, Pedro Blecua, PhD, Scott A Ely, MD, MPH, Olivier Elemento, PhD, Christopher E Mason, PhD, John P. Leonard, MD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2013) 122 (21): 80.
https://doi.org/10.1182/blood.V122.21.80.80
Published: 2013
Journal Articles

Everolimus for Relapsed/Refractory Classical Hodgkin Lymphoma: Multicenter, Open-Label, Single-Arm, Phase 2 Study.

Patrick B. Johnston, MD, PhD, Lauren Pinter-Brown, MD, Jaqueline Rogerio, MD, Ghulam Warsi, PhD, Quincy Chau, MD, MSc, Radhakrishnan Ramchandren, MD
Journal: Blood
Blood (2012) 120 (21): 2740.
https://doi.org/10.1182/blood.V120.21.2740.2740
Published: 2012
Journal Articles

Pillar-1: Multicenter Phase 2 Study of Everolimus for Patients with Mantle Cell Lymphoma Who Are Refractory or Intolerant to Bortezomib.

Michael Wang, M.D., Leslie Popplewell, MD, Robert H. Collins, Jr., MD, Jane N. Winter, MD, Andre Goy, MD, Anna Robeva, MS, Nicoletta Pirotta, Jenna Fan, Judith Klimovsky, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2751.
https://doi.org/10.1182/blood.V120.21.2751.2751
Published: 2012
Journal Articles

Is Multiple Sclerosis a Risk for Hypercoagulation States or Breast Cancer? A Case Report and a Literature Review to Assess Options

Lisa Thomas, MD, Qi Shi, MD, Sathyanarayanan Ramakrishnan, MD, Jihua Jia, MD, Linda Thomas-Hemak, MD
Journal: Blood
Blood (2011) 118 (21): 4665.
https://doi.org/10.1182/blood.V118.21.4665.4665
Published: 2011
Journal Articles

Sex Hormones Modulate the Length of Telomeres of Normal and Telomerase-Mutant Leukocytes through the Estrogen Receptor Pathway.

Rodrigo T. Calado, MD, PhD, William T. Yewdell, Keisha L. Wilkerson, Joshua A. Regal, BS, Sachiko Kajigaya, PhD, Neal S. Young, MD
Journal: Blood
Blood (2006) 108 (11): 182.
https://doi.org/10.1182/blood.V108.11.182.182
Published: 2006
Journal Articles

Thalidomide-Associated Thromboembolism in Cancer: Reimbursement for Thalidomide’s “Off-Label” Prescribing under the 2004 Medicare Oral Pharmaceutical Demonstration Project Raises Concerns.

Andrew M. Evens, DO, MS, June M. McKoy, MD, MPH, JD, Paul R. Yarnold, PhD, Kathyrn McCaffrey, BA, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2005) 106 (11): 2244.
https://doi.org/10.1182/blood.V106.11.2244.2244
Published: 2005